On p. 3371, in Figure 6A, the bottom representative image of Case #6 was inadvertently a duplicate of the middle image. The corrected Figure 6A is shown below.
Implications of MYD88L265P murine model for human LPL/WM. (A) MYD88 expression in plasmacytoid lymphocytes in BM biopsies from LPL/WM patients without (n = 11) and with (n = 13) MYD88L265P mutation as evaluated by IHC staining. Three representative examples per each group are shown. Note punctate cytoplasmic staining of the MYD88L265P, but not WT, protein. Scale bars, 5 μm. T-cell infiltration of BM biopsies from LPL/WM patients without (n = 13) and with (n = 13) the MYD88L265P mutation.
Implications of MYD88L265P murine model for human LPL/WM. (A) MYD88 expression in plasmacytoid lymphocytes in BM biopsies from LPL/WM patients without (n = 11) and with (n = 13) MYD88L265P mutation as evaluated by IHC staining. Three representative examples per each group are shown. Note punctate cytoplasmic staining of the MYD88L265P, but not WT, protein. Scale bars, 5 μm. T-cell infiltration of BM biopsies from LPL/WM patients without (n = 13) and with (n = 13) the MYD88L265P mutation.
